Breaking: Spain highlights Atlanta’s World Cup matches
COVID-19
COVID-19

J&J: Booster dose of its COVID shot prompts strong response

Johnson & Johnson's COVID-19 Vaccine Is 66% Effective in Global Trial.The single-shot vaccine was found to be 66% effective against moderate to severe illness in a global phase 3 trial.Against severe disease, the vaccine was 85% effective globally in adults of all ages and racial groups.In the United States, the vaccine was 72% effective against moderate and severe disease.Despite other vaccines being around 95% effective, experts say the Johnson & Johnson vaccine will still be useful.A vaccine that's inexpensive, that's a single dose, and that has no cold chain requirements — that's pretty good. , Dr. Anthony Fauci, via CNN.Johnson & Johnson is set to apply for emergency use authorization through the U.S. Food and Drug Administration next week, hoping for a late February rollout
By The Associated Press
Sept 21, 2021

LONDON — Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.

J&J said in statement Tuesday that it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults from ages 18 to 55. The study’s results haven’t yet been peer-reviewed.

ExploreComplete coverage: Coronavirus

“A booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,” said Dr. Mathai Mammen, global head of research and development at J&J.

The company is in talks with regulators including the U.S. Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine.

More Stories

The Latest

What's the difference between the coronavirus, the cold and influenza?

Coronavirus, cold or the flu? Here’s how to tell the difference

UPDATED: Coronavirus in Georgia: COVID-19 Dashboard

As pandemic ends, so could your Medicaid coverage: What to know in Georgia

Featured

Former Fulton County election worker Ruby Freeman talks to her daughter, Wandrea ArShaye "Shaye" Moss, a former Georgia election worker, after she testified before the U.S. House Select Committee at its fourth hearing on its Jan. 6 investigation on Capitol Hill in Washington, D.C., on Tuesday, June 21, 2022. (Yuri Gripas/Abaca Press/TNS)

Credit: TNS

OPINION

The 2020 election interference case is gone, but it can’t be forgotten

The decision by a Georgia prosecutor not to pursue the massive Trump election interference case leaves some bad deeds unpunished.

Officials to install opioid reversal kits in Georgia’s public schools

The kits will contain Narcan, which can temporarily reverse the effects of an opioid overdose and restore breathing.

Odom-led comeback nets Conference USA championship for Kennesaw State

The Owls continue to be one of the most intriguing stories of the season, going from a two-win season to a conference title and beating the defending league champions.